2022
DOI: 10.1016/j.cveq.2022.05.006
|View full text |Cite
|
Sign up to set email alerts
|

Equine Herpesvirus-1 Myeloencephalopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
19
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(21 citation statements)
references
References 85 publications
0
19
0
Order By: Relevance
“…While molecular tests (e.g. PCR) are able to identify the EHVs in any fluid and tissue, IHC (together with in situ hybridisation) has the advantage to confirm clinical suspect of equine herpesviral encephalomyelopathy, when viral antigens are highlighted in endothelial cells (Pusterla et al, 2022).…”
Section: Infec Ti Ous Ag Entsmentioning
confidence: 99%
“…While molecular tests (e.g. PCR) are able to identify the EHVs in any fluid and tissue, IHC (together with in situ hybridisation) has the advantage to confirm clinical suspect of equine herpesviral encephalomyelopathy, when viral antigens are highlighted in endothelial cells (Pusterla et al, 2022).…”
Section: Infec Ti Ous Ag Entsmentioning
confidence: 99%
“…EHM typically affects less than 10% of infected horses in EHV‐1 outbreaks 3,6 . However, EHM can cause devastating losses during outbreaks 7–11 and the international nature of equestrian sport can lead to rapid dissemination across national boundaries 10,11…”
Section: Introductionmentioning
confidence: 99%
“…In suspected EHV‐1 outbreaks, rapid diagnosis is vital, and real‐time PCR has become the technique of choice 2,7,12 . Accurate diagnosis in outbreaks also relies on obtaining the best possible sample at the best possible time 13,14 .…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations